|
Home : Unsafe Drugs : Avandia : News Articles : FDA Drug Safety Communication: Avandia (rosiglitazone) labels now contain updated information about cardiovascular risks and use in certain patients | Bioscience Technology Online FDA Drug Safety Communication: Avandia (rosiglitazone) labels now contain updated information about cardiovascular risks and use in certain patients | Bioscience Technology Online
Rosiglitazone is sold as a single-ingredient product under the brand name Avandia. Rosiglitazone is also sold as a combination product under the brand name Avandaryl (contains rosiglitazone and glimepiride). In addition to describing the cardiovascular risks, the drug labels have been revised to ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




